Single early postoperative instillation in superficial bladder carcinoma - Current status;Die frühinstillation des harnblasenkarzinoms: Eine standortbestimmung

Urologe - Ausgabe A

Volumn 43, Issue 12, 2004, Pages 1531-1536

  Langbein, S ^a   Hacker A ^a   Badawi, J K ^a   Michel, M S ^a   Alken, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Early postoperative instillation; Instillation time; Superficial bladder carcinoma; Time of intravesical application

Indexed keywords

ADHESION; BLADDER CARCINOMA; BLADDER IRRIGATION; CANCER RECURRENCE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); FOLLOW UP; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; REOPERATION; REVIEW; TRANSURETHRAL RESECTION; TUMOR CELL;

ADMINISTRATION, INTRAVESICAL; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE CARE; PRACTICE GUIDELINES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 12144257247     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-004-0720-5     Document Type: Review

References (18)

1. Au JL, Badalament RA, Wientjes MG, Young DC et al. (2001) Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst 93 (8): 597-604
2. Beisland HO, Seland P (1986) A prospective randomized study on neodym-yag laser Irridation versus TUR in the treatment of urinary bladder cancer. Scand J Urol Nephrol 20: 209-212
3. Bouffioux C, Kurth KH, Bono A et al. (1995) Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group. J Urol Mar 153 (3 Pt 2): 934-941
4. Burnand KG, Boyd PJ, Mayo ME et al. (1976) Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional call bladder carcinoma. BJU 48: 55-59
5. Calais da Silva F, Denis L, Bono A, Bollack C, Bouffioux C (1988) Intravesical chemoresection with 4′-epi-doxorubicin in patients with superficial bladder tumors. Eur Urol 14 (3): 207-209
6. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Rossler W (2003) Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study. Urologe A 42 (10): 1366-1373
7. Kaasinen E, Rintala E, Hellström P et al. (2002) Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma. Europ Urol 42: 167-174
8. Mack D, Rammal E, Jakse G (1988) Iatrogenic Tumorzellimplantation beim Blasenkarzinom. Urologe A 27: 99-104
9. Müller F, Kraft R, Zingg EJ (1985) Exfoliative cytology after transurethral resection of superficial bladder tumours. Br J Urol 57: 530
10. Newling DW, Hetherington J, Sundaram SK, Robinson MR, Kisbenedek L (2001) The use of valrubicin for the chemoresection of superficial bladder cancer - a maker lesion study. Eur Urol 39(6): 643-647
11. Oosterlinck W, Lobel B, Jakse G, Malmström P-U, Stöckle M, Sternberg C (eds) (2001) Guidelines on bladder cancer. European Association of Urology. http://www.uroweb.org, pp 8-11
12. Pode D, Alon Y, Horowitz AT, Vlodavsky I, Biran S (1986) The mechanism of human bladder tumor implantation in an in vitro model. J Urol 136(2): 482-486
13. Popert RJ, Goodall J, Coptcoat MJ, Thompson PM, Parmar MK, Masters JR (1994) Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicin. Br J Urol 74 (2): 195-199
14. Rajala P, Liukkonen T, Raitanen M et al. (1999) Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study - Finnbladder III. J Urol 161 (4): 1133-1135
15. Rajala P, Kaasinen E, Raitanen M, Liukkonen T, Rintala E, Finnbladder Group (2002) Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study - Finnbladder III long-term results. J Urol 168 (3): 981-985
16. Semple JE (1948) Papillomata of bladder treated with podophyllin. Br Med J 26: 1235-1237
17. Soloway MS, Masters S (1980) Urothelial susceptibility to tumor cell implantation: influence of cauterisation. Cancer 46: 1158
18. Sylvester RJ, Oosterlinck W, van der Meijden AP (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171: 2186-2190